Stockholm - Free Realtime Quote SEK
Genovis AB (publ.) (GENO.ST)
25.15
-0.30
(-1.18%)
As of 9:15:57 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
29,678
37,116
67,752
-928
45,918.90
Investing Cash Flow
14,996
14,422
-12,808
-3,825
-4,491.23
Financing Cash Flow
-6,057
-5,357
-4,513
-3,732
-4,230.48
End Cash Position
175,410
169,442
123,261
72,830
81,314.99
Capital Expenditure
--
-4,799
-12,808
-3,825
-4,491.23
Issuance of Capital Stock
--
--
--
--
0
Free Cash Flow
24,879
32,317
54,944
-4,753
41,427.67
12/31/2021 - 6/2/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CHOSA.ST CHOSA Oncology AB
0.7750
0.00%
QUIA.ST Quia Pharma AB (publ)
0.0052
0.00%
HMGN Hemagen Diagnostics, Inc.
0.0001
0.00%
DBP-B.ST Double Bond Pharmaceutical Int.
0.1330
0.00%
ERGO Entia Biosciences, Inc.
0.0002
+100.00%
IMMU.ST Mendus AB (publ)
4.9450
-4.54%
0NZU.IL Zealand Pharma A/S
483.40
+1.19%
XSPRAY.ST Xspray Pharma AB (publ)
30.60
-4.37%
2CUREX.ST 2cureX AB (publ)
5.36
+3.88%
KAN.ST Kancera AB (publ)
1.1500
+2.68%